Muscle strength, Na,K‐pumps, magnesium and potassium in patients with alcoholic liver cirrhosis – relation to spironolactone [PDF]
Niels Kristian Aagaard+5 more
openalex +1 more source
The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment. [PDF]
Taub PR, Greene SJ, Fudim M.
europepmc +1 more source
Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin [PDF]
Amitava Dasgupta+3 more
openalex +1 more source
Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide [PDF]
Yoshitaka Hayashi+3 more
openalex +1 more source
Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis. [PDF]
Yu W+7 more
europepmc +1 more source
PCD12: SPIRONOLACTONE IN HEART FAILURE: LIFE AND COST SAVING TREATMENT IN POLAND
J Kuźniar+2 more
openalex +1 more source
Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan. [PDF]
Chien LN+8 more
europepmc +1 more source